Subcutaneous insulin: pharmacokinetic variability and glycemic variability
- 23 September 2005
- journal article
- review article
- Published by Elsevier in Diabetes & Metabolism
- Vol. 31 (4), 4S7-4S24
- https://doi.org/10.1016/s1262-3636(05)88263-1
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- The reality of glycaemic control in insulin treated diabetes: defining the clinical challengesInternational Journal of Obesity, 2004
- Pathophysiology of insulin secretionAnnales d'Endocrinologie, 2004
- Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyBMJ, 2000
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research GroupDiabetes, 1997
- The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications TrialDiabetes, 1996
- United Kingdom Prospective Diabetes Study 17: A 9-Year Update of a Randomized, Controlled Trial on the Effect of Improved Metabolic Control on Complications in Non-Insulin-dependent Diabetes MellitusAnnals of Internal Medicine, 1996
- Adverse Events and Their Association With Treatment Regimens in the Diabetes Control and Complications TrialDiabetes Care, 1995
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects.Journal of Clinical Investigation, 1988